{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:36:45Z","timestamp":1773297405918,"version":"3.50.1"},"reference-count":40,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1210\/jc.2007-0334","type":"journal-article","created":{"date-parts":[[2007,5,16]],"date-time":"2007-05-16T01:10:58Z","timestamp":1179277858000},"page":"2885-2892","source":"Crossref","is-referenced-by-count":132,"title":["Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk"],"prefix":"10.1210","volume":"92","author":[{"given":"Ele","family":"Ferrannini","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Consiglio Nazionale delle Ricerche Institute of Clinical Physiology (E.F., A.N.), University of Pisa, I-56100 Pisa, Italy"}]},{"given":"Beverley","family":"Balkau","sequence":"additional","affiliation":[{"name":"Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (B.B.), U 780-IFR69, F-94807 Villejuif, France"}]},{"given":"Simon W.","family":"Coppack","sequence":"additional","affiliation":[{"name":"Department of Academic Medical Unit (S.W.C.), The Royal London Hospital, London E1 1BB, United Kingdom"}]},{"given":"Jacqueline M.","family":"Dekker","sequence":"additional","affiliation":[{"name":"Department of Extramuraal Geneeskundig Onderzoek (EMGO) Institute (J.M.D.), Vrije Universiteit Medical Center, 1081 BV Amsterdam, The Netherlands"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[{"name":"Department of Consiglio Nazionale delle Ricerche Institute of Biomedical Engineering (A.M.), I-35127 Padova, Italy"}]},{"given":"John","family":"Nolan","sequence":"additional","affiliation":[{"name":"Department of Medicine (J.N.), Trinity College, Dublin 2, Ireland"}]},{"given":"Mark","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Medicine (M.W.), University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HQ, United Kingdom"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Consiglio Nazionale delle Ricerche Institute of Clinical Physiology (E.F., A.N.), University of Pisa, I-56100 Pisa, Italy"}]},{"given":"Henning","family":"Beck-Nielsen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology M (H.B.-N.), Odense University Hospital, DK-5000 Odense, Denmark"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113425433500_R1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2337\/diacare.46.10.1594","article-title":"Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.","volume":"46","author":"Meigs","year":"1997","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00403180","article-title":"Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.","volume":"34","author":"Ferrannini","year":"1991","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113425433500_R3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","article-title":"An investigation of coronary heart disease in families: the Framingham Offspring Study.","volume":"110","author":"Kannel","year":"1979","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t2019041113425433500_R4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198903163201105","article-title":"Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.","volume":"320","author":"Zavaroni","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113425433500_R5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease.","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1993.tb00700.x","article-title":"Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia.","volume":"234","author":"Zavaroni","year":"1993","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041113425433500_R7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI116541","article-title":"Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.","volume":"92","author":"Reaven","year":"1993","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113425433500_R8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4158\/EP.9.S2.50","article-title":"Insulin resistance syndrome and the prothrombotic state: a Framingham perspective","volume":"9","author":"Wilson","year":"2003","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113425433500_R9","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1097\/01.ASN.0000133698.80390.37","article-title":"The relationship between hyperinsulinemia, hypertension and progressive renal disease.","volume":"15","author":"El-Atat","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113425433500_R10","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ.","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113425433500_R11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/07853890510037383","article-title":"Fat in the liver and insulin resistance.","volume":"37","author":"Yki-Ja\u0308rvinen","year":"2005","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t2019041113425433500_R12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart.","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key\n\t\t\t\t2019041113425433500_R13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/07853890500383895","article-title":"Is visceral obesity the cause of the metabolic syndrome?","volume":"38","author":"Despres","year":"2006","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t2019041113425433500_R14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113425433500_R15","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.2337\/diabetes.54.9.2720","article-title":"Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.","volume":"54","author":"Virtanen","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.beem.2005.07.004","article-title":"Human fat cell lipolysis: biochemistry, regulation and clinical role.","volume":"19","author":"Arner","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113425433500_R17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncpcardio0380","article-title":"Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease.","volume":"3","author":"Matsuzawa","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key\n\t\t\t\t2019041113425433500_R18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease.","volume":"96","author":"Berg","year":"2005","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019041113425433500_R19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/diabetes.54.5.1364","article-title":"The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans.","volume":"54","author":"Andrew","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R20","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/diabetes.53.8.2087","article-title":"Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.","volume":"53","author":"Carr","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R21","first-page":"566","article-title":"The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.","volume-title":"Diabetologia","author":"Hills","year":"2004"},{"key":"key\n\t\t\t\t2019041113425433500_R22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/clinchem\/39.4.578","article-title":"Enzyme immunoassay for intact human insulin in serum or plasma.","volume":"39","author":"Andersen","year":"1993","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113425433500_R23","first-page":"S4","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume-title":"Diabetes Care","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2000"},{"key":"key\n\t\t\t\t2019041113425433500_R24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00004872-199816070-00001","article-title":"How to measure insulin sensitivity.","volume":"16","author":"Ferrannini","year":"1998","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113425433500_R25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","article-title":"Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113425433500_R26","first-page":"857","article-title":"Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference.","volume-title":"Am J Clin Nutr","author":"Stolk","year":"2003"},{"key":"key\n\t\t\t\t2019041113425433500_R27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00125-004-1381-z","article-title":"Beta cell function and its relation to insulin action in humans: a critical appraisal.","volume":"47","author":"Ferrannini","year":"2004","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113425433500_R28","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.","volume":"329","author":"Lillioja","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113425433500_R29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113425433500_R30","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s00125-005-0004-7","article-title":"Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.","volume":"48","author":"Walker","year":"2005","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113425433500_R31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1566524053766086","article-title":"Type 2 diabetes as a lipid disorder.","volume":"5","author":"Taskinen","year":"2005","journal-title":"Curr Mol Med"},{"key":"key\n\t\t\t\t2019041113425433500_R32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2007-1014753","article-title":"Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers.","volume":"16","author":"Reaven","year":"1984","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113425433500_R33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00400466","article-title":"Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man.","volume":"37","author":"Del Prato","year":"1994","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113425433500_R34","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1152\/ajpendo.00203.2004","article-title":"Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance","volume":"288","author":"Kabir","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113425433500_R35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1467-789x.2001.00027.x","article-title":"Do stress reactions cause abdominal obesity and comorbidities?","volume":"2","author":"Bjorntorp","year":"2001","journal-title":"Obes Rev"},{"key":"key\n\t\t\t\t2019041113425433500_R36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2337\/diab.30.3.219","article-title":"Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.","volume":"30","author":"Rowe","year":"1981","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1357-2725(02)00311-4","article-title":"The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?","volume":"35","author":"Engeli","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"key\n\t\t\t\t2019041113425433500_R38","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2337\/diabetes.51.8.2642","article-title":"Factor analysis of metabolic syndrome using directly measured insulin sensitivity. The Insulin Resistance Atherosclerosis Study.","volume":"51","author":"Hanley","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113425433500_R39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/diacare.29.01.06.dc05-0862","article-title":"A single factor underlies the metabolic syndrome: a confirmatory factor analysis.","volume":"29","author":"Pladevall","year":"2006","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113425433500_R40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/aje\/kwh150","article-title":"(Mis)use of factor analysis in the study of insulin resistance syndrome.","volume":"159","author":"Lawlor","year":"2004","journal-title":"Am J Epidemiol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/8\/2885\/10403291\/jcem2885.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T01:23:39Z","timestamp":1587518619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/8\/2885\/2597295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-0334","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}